Dyne Therapeutics, Inc. Common Stock

DYNNASDAQ • USD
17.16 USD
↗ 0.15 (0.88%)AT CLOSE (03:59 PM EST)
17.16
↘ 0.01 (0.03%)
POST MARKET (AS OF 04:15 PM EST)
Post Market
AS OF 04:15 PM EST
17.16
↘ 0.01 (0.03%)
🔴Market: CLOSED

Shares of Dyne Therapeutics, Inc. Common Stock (DYN) are trading at $17.17. The technical outlook is "Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. DYN is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$16.90
High?$17.35
Low?$16.42
Prev. Close?$17.01
Volume?1.7M
Avg. Volume?2.8M
VWAP?$17.04
Rel. Volume?0.59x
Bid / Ask
Bid?$16.26 × 300
Ask?$17.47 × 200
Spread?$1.21
Midpoint?$16.87
Valuation & Ratios
Market Cap?3.2B
Shares Out?187.3M
Float?173.8M
Float %?93.1%
P/E Ratio?N/A
P/B Ratio?3.45
EPS?-$3.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Employees
258
Market Cap
3.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-09-17
Address
1560 TRAPELO ROAD
WALTHAM, MA 02451
Phone: (781) 786-8230
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
86
Momentum?
50
Short Sent.?
48
Piotroski F-Score?0/9Weak
Altman Z-Score?3.60Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?14.02%High
Short Interest?24.4M
Days to Cover?10.8
Free Float173.8M
Avg Daily Volume2.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?12.99Strong
Quick Ratio?12.99Strong
Cash Ratio?10.09Strong
Debt/Equity?0.24Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
49
3.45FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-65.0%WEAK▾
ROA?
S&P
3
-49.0%WEAK▾
Cash Flow & Enterprise
FCF?$-568761000
Enterprise Value?$2.5B
Fundamentals ratios updated end of day